Gilead Sciences logo

Gilead Sciences dividendNASDAQ: GILD

TTMAnnual

Dividend per share (last paid)

$0.77
$0.000.00%

13 September 2024

Dividend per share (next)

-

new highvs 3 years high
+8.45%vs 3 years low
Performance
Most recent0.0%
1 year+2.7%
3 years+8.4%
5 years+22.2%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend per share (last paid) performance

Most recent change
GILD0.0%
BSX-
MDT0.0%
SNY+7.2%
VRTX-
BMY0.0%
SYK0.0%
1 year change
GILD+2.7%
BSX-
MDT+1.4%
SNY+7.2%
VRTX-
BMY+5.3%
SYK+6.7%
3 years change
GILD+8.4%
BSX-
MDT+11.1%
SNY+5.6%
VRTX-
BMY+22.4%
SYK+27.0%
5 years change
GILD+22.2%
BSX-
MDT+29.6%
SNY+17.1%
VRTX-
BMY+46.3%
SYK+53.9%

Dividend per share (last paid) performance

GILDBSXMDTSNYVRTXBMYSYK
Most recent0.0%-0.0%+7.2%-0.0%0.0%
1 year+2.7%-+1.4%+7.2%-+5.3%+6.7%
3 years+8.4%-+11.1%+5.6%-+22.4%+27.0%
5 years+22.2%-+29.6%+17.1%-+46.3%+53.9%
FAQ

What is Gilead Sciences dividend per share (last paid)?

Gilead Sciences dividend per share (last paid) is $0.77

What is Gilead Sciences dividend per share (last paid) compared to its all-time maximum value?

Gilead Sciences dividend per share (last paid) is 100% of its all-time maximum value

How has Gilead Sciences dividend per share (last paid) changed over the year?

Over the past year, Gilead Sciences dividend per share (last paid) has increased by 2.7%. During the same period, , Medtronic has risen by 1.4%, Sanofi has grown by 7.2%, Bristol-Myers Squibb has risen by 5.3%, Stryker has grown by 6.7%

How has Gilead Sciences dividend per share (last paid) changed over the 3 years?

During the last 3 years, Gilead Sciences dividend per share (last paid) has increased by 8.4%. Over the same period, , Medtronic has risen by 11.1%, Sanofi has grown by 5.6%, Bristol-Myers Squibb has risen by 22.4%, Stryker has grown by 27.0%

How has Gilead Sciences dividend per share (last paid) changed over the 5 years?

For the past 5 years, Gilead Sciences dividend per share (last paid) has increased by 22.2%. In the same period, , Medtronic has risen by 29.6%, Sanofi has grown by 17.1%, Bristol-Myers Squibb has risen by 46.3%, Stryker has grown by 53.9%